Tina Mayer

3.1k total citations · 1 hit paper
64 papers, 881 citations indexed

About

Tina Mayer is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology. According to data from OpenAlex, Tina Mayer has authored 64 papers receiving a total of 881 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Pulmonary and Respiratory Medicine, 18 papers in Cancer Research and 14 papers in Molecular Biology. Recurrent topics in Tina Mayer's work include Prostate Cancer Treatment and Research (21 papers), Renal cell carcinoma treatment (13 papers) and Cancer Genomics and Diagnostics (9 papers). Tina Mayer is often cited by papers focused on Prostate Cancer Treatment and Research (21 papers), Renal cell carcinoma treatment (13 papers) and Cancer Genomics and Diagnostics (9 papers). Tina Mayer collaborates with scholars based in United States, Botswana and South Korea. Tina Mayer's co-authors include Joachim M. Baehring, Kevin Anton, Gregory Riedlinger, Shridar Ganesan, Mark N. Stein, Eric A. Singer, Salma K. Jabbour, Eugenia Girda, Ann W. Silk and Aliza Leiser and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Tina Mayer

59 papers receiving 875 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers

2021 196 citations Matteo Palmeri, Janice M. Mehnert et al. ESMO Open profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tina Mayer United States	12	323	321	308	190	110	64	881
Agda Karina Eterovic United States	14	171 0.5×	487 1.5×	389 1.3×	297 1.6×	126 1.1×	30	1.0k
Shogo Kumagai Japan	15	389 1.2×	450 1.4×	216 0.7×	144 0.8×	177 1.6×	37	1.0k
Jinyoung Yoo South Korea	20	334 1.0×	324 1.0×	458 1.5×	112 0.6×	128 1.2×	64	1.1k
Laurent Doucet France	19	385 1.2×	159 0.5×	285 0.9×	185 1.0×	97 0.9×	49	975
Jamel Daoud Tunisia	22	190 0.6×	540 1.7×	472 1.5×	271 1.4×	99 0.9×	71	1.2k
Diana Romero United States	19	281 0.9×	394 1.2×	563 1.8×	199 1.0×	50 0.5×	176	1.2k
Alejandro Avilés‐Salas Mexico	14	249 0.8×	369 1.1×	295 1.0×	186 1.0×	65 0.6×	62	768
Xiaofan Lu China	17	406 1.3×	245 0.8×	391 1.3×	279 1.5×	67 0.6×	60	938
Melissa C. Larson United States	18	200 0.6×	354 1.1×	370 1.2×	177 0.9×	55 0.5×	77	1.0k
Jennifer Ma United States	14	169 0.5×	321 1.0×	253 0.8×	185 1.0×	121 1.1×	54	817

Countries citing papers authored by Tina Mayer

Since Specialization

Citations

This map shows the geographic impact of Tina Mayer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tina Mayer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tina Mayer more than expected).

Fields of papers citing papers by Tina Mayer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tina Mayer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tina Mayer. The network helps show where Tina Mayer may publish in the future.

Co-authorship network of co-authors of Tina Mayer

This figure shows the co-authorship network connecting the top 25 collaborators of Tina Mayer. A scholar is included among the top collaborators of Tina Mayer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tina Mayer. Tina Mayer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Deek, Matthew P., Xiaolei Shi, Noura Radwan, et al.. (2025). Phase 2 randomized study of high-risk metachronous oligometastatic prostate cancer with high-risk mutations treated with metastasis-directed therapy and niraparib/abiraterone acetate plus prednisone (KNIGHTS) trial.. Journal of Clinical Oncology. 43(5_suppl). 1 indexed citations

Sutera, Philip, Jongmyung Kim, Ritesh Kumar, et al.. (2024). PIK3/Akt/mTOR pathway alterations in metastatic castration‐sensitive prostate cancer. The Prostate. 84(14). 1301–1308. 2 indexed citations

Pfail, John, Biren Saraiya, Tina Mayer, et al.. (2023). Metastasis-Directed Therapy for Oligometastatic Castration-Sensitive Prostate Cancer: An Alternative to ADT?. Current Urology Reports. 24(7). 299–306. 1 indexed citations

Shah, Ankit, et al.. (2023). Pilot Study Evaluating Cross-Disciplinary Educational Material to Improve Patients’ Knowledge of Palliative Radiation Therapy. Journal of Cancer Education. 38(5). 1466–1470.

Shinder, Brian, Sinae Kim, Arnav Srivastava, et al.. (2023). Factors associated with clinical trial participation for patients with renal cell carcinoma. Urologic Oncology Seminars and Original Investigations. 41(4). 208.e1–208.e8. 1 indexed citations

Patel, Hiren V., Sinae Kim, Arnav Srivastava, et al.. (2022). Factors Associated With Palliative Intervention Utilization for Metastatic Renal Cell Carcinoma. Clinical Genitourinary Cancer. 20(3). 296–296.e9. 11 indexed citations

Kim, Isaac Yi, Antonina Mitrofanova, Sukanya Panja, et al.. (2022). Genomic analysis and long-term outcomes of a phase 1 clinical trial on cytoreductive radical prostatectomy. Prostate International. 10(2). 75–79. 8 indexed citations

Palmeri, Matteo, Janice M. Mehnert, Ann W. Silk, et al.. (2021). Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers. ESMO Open. 7(1). 100336–100336. 196 indexed citations breakdown →

Srivastava, Arnav, Zorimar Rivera‐Núñez, Sinae Kim, et al.. (2020). Impact of pathologic lymph node‐positive renal cell carcinoma on survival in patients without metastasis: Evidence in support of expanding the definition of stage IV kidney cancer. Cancer. 126(13). 2991–3001. 22 indexed citations

10.

Shah, Mansi, et al.. (2020). Combination drug regimens for metastatic clear cell renal cell carcinoma. World Journal of Clinical Oncology. 11(8). 541–562. 16 indexed citations

11.

Srivastava, Arnav, Hiren V. Patel, Sinae Kim, et al.. (2020). Delaying surgery for clinical T1b-T2bN0M0 renal cell carcinoma: Oncologic implications in the COVID-19 era and beyond. Urologic Oncology Seminars and Original Investigations. 39(5). 247–257. 8 indexed citations

12.

Bitting, Rhonda L., Patrick Healy, Daniel J. George, et al.. (2020). Phase II Trial of Enzalutamide and Androgen Deprivation Therapy with Salvage Radiation in Men with High-risk Prostate-specific Antigen Recurrent Prostate Cancer: The STREAM Trial. European Urology Oncology. 4(6). 948–954. 23 indexed citations

13.

Kim, Isaac Yi, Sinae Kim, Arnav Srivastava, et al.. (2019). Similar incidence of DNA damage response pathway alterations between clinically localized and metastatic prostate cancer. BMC Urology. 19(1). 33–33. 8 indexed citations

14.

Weiss, Robert E., Amal Mansour, Claude E. Monken, et al.. (2019). Phase I neoadjuvant study of intravesical recombinant fowlpox-GM-CSF (rF-GM-CSF) or fowlpox-TRICOM (rF-TRICOM) in patients with bladder carcinoma. Cancer Gene Therapy. 27(6). 438–447. 6 indexed citations

15.

Yuh, Bertram, Young Suk Kwon, Brian Shinder, et al.. (2018). Results of Phase 1 study on cytoreductive radical prostatectomy in men with newly diagnosed metastatic prostate cancer. Prostate International. 7(3). 102–107. 18 indexed citations

16.

Farber, Nicholas, Zorimar Rivera‐Núñez, Sinae Kim, et al.. (2018). Trends and outcomes of lymphadenectomy for nonmetastatic renal cell carcinoma: A propensity score-weighted analysis of the National Cancer Database. Urologic Oncology Seminars and Original Investigations. 37(1). 26–32. 11 indexed citations

17.

Ferrari, Anna C., et al.. (2017). Dramatic mixed response of lymphangitic pulmonary metastases in newly diagnosed prostate cancer. Urology Annals. 9(3). 278–278. 2 indexed citations

18.

Ferrari, Alessio, G. R. Hudes, Michael A. Carducci, et al.. (2016). E2809. Androgen receptor (AR) modulation by bicalutamide (Bic) and MK-2206 (MK) in prostate cancer (PC) patients (pts) with rising PSA at high risk of progression after local treatment (tx). Annals of Oncology. 27. vi249–vi249. 1 indexed citations

19.

Stein, Mark N., et al.. (2012). A randomized phase II study of bicalutamide (BIC) followed by placebo or gamma secretase inhibitor RO4929097 (RO492) in men with rising PSA.. Journal of Clinical Oncology. 30(5_suppl). 219–219. 6 indexed citations

20.

Kluger, Harriet M., Kathleen Hoyt, Antonella Bacchiocchi, et al.. (2011). Plasma Markers for Identifying Patients with Metastatic Melanoma. Clinical Cancer Research. 17(8). 2417–2425. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact